Argoff on Neurology

 
 
  • Game-Changing Opioid Labeling   This news has many practice implications for prescribers and poses unanswered questions about the response of industry.
  • Should Hydrocodone Be Rescheduled?   A pain expert weighs in on an FDA advisory committee's recent vote in favor of reclassifying hydrocodone-containing medications as schedule II.
  • Optimal Opioid Therapy and Redefining Cancer-Related Pain   Dr. Charles Argoff discusses 2 important concerns to consider when managing chronic pain.
  • Managing Opioid-Induced Constipation   Dr. Charles Argoff looks at current approaches and a potential new therapy for constipation associated with opioid use.
  • Using Muscle Relaxants in Chronic Pain   Dr. Charles Argoff reviews muscle relaxant medications to consider when managing patients with chronic pain.
  • Pain Complaints: When to Order a Skin Biopsy   Dr. Charles Argoff discusses the case of a 20-year-old woman complaining of painful burning in the lower extremities.
  • Better Pain Control by...Cutting Back on Opioids?   A new study looks at medicinal marijuana’s potential as an adjunct to opioid therapy in chronic pain.
  • Does Your Patient Really Have Fibromyalgia?   Dr. Charles Argoff reviews conditions that can mimic fibromyalgia. Differential diagnosis is key.
  • Prescription Painkiller ODs Now 'Epidemic': What Can Be Done?   According to the CDC, prescription painkiller overdoses now kill more Americans than cocaine and heroin combined. How can the problem be addressed?
  • Topicals in Pain Management: A Review   What topical analgesics are available and what is their role in pain management?
  • A Look at Botox in Chronic Migraine   Dr. Charles Argoff recounts 2 cases of chronic treatment-refractory migraine and the role onabotulinumtoxinA played in managing these patients.
  • My Patient Wants Pain Meds, But Where Are the Records?   Incomplete records. An inconsistent history. Dr. Charles Argoff discusses how to proceed with pain care when a patient’s history just doesn’t add up.
  • An Approach to Intractable Headache   Dr. Charles Argoff discusses how to manage patients with intractable headaches due to medication overuse.
  • How Can PCPs and Pain Docs Curb Opioid Abuse?   Dr. Charles Argoff discusses a new SAMHSA report on the growing problem of prescription drug abuse in the United States. How can PCPs and pain specialists help address the problem?
  • How Can Effective Chronic Pain Care Be Achieved?   Dr. Charles Argoff discusses the Institute of Medicine’s new report detailing what efforts are necessary to optimize chronic pain management in the United States.
  • A Novel Way to Predict Chronic Pain?   Can structural changes in the brain predict chronic lower back pain? Dr. Charles Argoff discusses this fascinating study from this year’s American Academy of Pain Medicine Annual Meeting, among other conference highlights.
  • Diabetic Neuropathy: Interpreting New Guidelines   Dr. Charles Argoff discusses the treatment implications of new AAN guidelines for managing painful diabetic neuropathy.
  • Prescription Drug Abuse: Addressing the Epidemic   The US government recently unveiled a multiagency-backed plan to address the prescription drug abuse epidemic. How can prescribers further address the problem?
  • Opioid REMS: Is it Enough?   Dr. Charles Argoff weighs in on the FDA's new plan to regulate the use of long-acting and extended-release opioids. Is it enough to help curb the alarming rate of prescription drug abuse?
  • What's New in Pain Management?   What's new in pain management? Dr. Charles Argoff discusses highlights from the American Academy of Pain Medicine's annual meeting.